FDA
- Status: approved
Intrapleurally Alteplase vs Intrapleurally Urokinase (Intrapleurally Alteplase vs Intrapleurally Urokinase) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Hospital Universitari Vall d'Hebron Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.